肿瘤研究与临床
腫瘤研究與臨床
종류연구여림상
CANCER RESEARCH AND CLINIC
2009年
2期
87-90
,共4页
周智锋%叶韵斌%李洁羽%陈强%黄伟炜
週智鋒%葉韻斌%李潔羽%陳彊%黃偉煒
주지봉%협운빈%리길우%진강%황위위
乳腺肿瘤%杀伤细胞,天然%基因,MHCⅠ类
乳腺腫瘤%殺傷細胞,天然%基因,MHCⅠ類
유선종류%살상세포,천연%기인,MHCⅠ류
Breast neoplasms%Killer cells,natural%Genes,MHC class Ⅰ
目的 观察乳腺癌患者外周血自然杀伤(NK)细胞杀伤活性及受体的变化,探讨可溶性MICA(sMICA)对NK细胞受体及杀伤活性的影响.方法 ELISA法检测外周血血清sMICA的含量.流式细胞术(FCM)检测NK细胞百分比、NK细胞活化性受体NKG2D、抑制性受体KIR(CD158b)表达.MTT法检测NK细胞对乳腺癌细胞株MCF-7的杀伤活性.结果 与健康人比较,乳腺癌患者中81.6%表达sMICA,含量为(205.36±71.27)ng/L,且sMICA含量与TNM分期呈正相关.乳腺癌患者外周血NK细胞所占百分比无明显差异,但血清sMICA阳性的乳腺癌患者中NK细胞杀伤活性明显降低,NKG2D表达下降,CD158b表达增高.当NK细胞培养体系中加入sMICA阳性的乳腺癌血清时,其杀瘤活性明显降低[(76.2±6.7)%与(48.4±4.1)%],NKG2D的表达明显下调[(92.5±7.1)%与(62.5±6.4)%],而CD158b的表达明显上升[(10.6±3.2)%与(43.6±3.4)%].sMICA阳性的乳腺癌患者NK细胞与细胞因子IL-15共培养,NK细胞的杀瘤活性、NKG2D的表达明显升高,KIR(CD158b)的表达明显下降.结论 乳腺癌外周血血清中sMICA可通过下调NK细胞NKG2D表达以及上调KIR表达,降低NK细胞杀瘤活性.IL-15可逆转sMICA对NK细胞的免疫下调作用.
目的 觀察乳腺癌患者外週血自然殺傷(NK)細胞殺傷活性及受體的變化,探討可溶性MICA(sMICA)對NK細胞受體及殺傷活性的影響.方法 ELISA法檢測外週血血清sMICA的含量.流式細胞術(FCM)檢測NK細胞百分比、NK細胞活化性受體NKG2D、抑製性受體KIR(CD158b)錶達.MTT法檢測NK細胞對乳腺癌細胞株MCF-7的殺傷活性.結果 與健康人比較,乳腺癌患者中81.6%錶達sMICA,含量為(205.36±71.27)ng/L,且sMICA含量與TNM分期呈正相關.乳腺癌患者外週血NK細胞所佔百分比無明顯差異,但血清sMICA暘性的乳腺癌患者中NK細胞殺傷活性明顯降低,NKG2D錶達下降,CD158b錶達增高.噹NK細胞培養體繫中加入sMICA暘性的乳腺癌血清時,其殺瘤活性明顯降低[(76.2±6.7)%與(48.4±4.1)%],NKG2D的錶達明顯下調[(92.5±7.1)%與(62.5±6.4)%],而CD158b的錶達明顯上升[(10.6±3.2)%與(43.6±3.4)%].sMICA暘性的乳腺癌患者NK細胞與細胞因子IL-15共培養,NK細胞的殺瘤活性、NKG2D的錶達明顯升高,KIR(CD158b)的錶達明顯下降.結論 乳腺癌外週血血清中sMICA可通過下調NK細胞NKG2D錶達以及上調KIR錶達,降低NK細胞殺瘤活性.IL-15可逆轉sMICA對NK細胞的免疫下調作用.
목적 관찰유선암환자외주혈자연살상(NK)세포살상활성급수체적변화,탐토가용성MICA(sMICA)대NK세포수체급살상활성적영향.방법 ELISA법검측외주혈혈청sMICA적함량.류식세포술(FCM)검측NK세포백분비、NK세포활화성수체NKG2D、억제성수체KIR(CD158b)표체.MTT법검측NK세포대유선암세포주MCF-7적살상활성.결과 여건강인비교,유선암환자중81.6%표체sMICA,함량위(205.36±71.27)ng/L,차sMICA함량여TNM분기정정상관.유선암환자외주혈NK세포소점백분비무명현차이,단혈청sMICA양성적유선암환자중NK세포살상활성명현강저,NKG2D표체하강,CD158b표체증고.당NK세포배양체계중가입sMICA양성적유선암혈청시,기살류활성명현강저[(76.2±6.7)%여(48.4±4.1)%],NKG2D적표체명현하조[(92.5±7.1)%여(62.5±6.4)%],이CD158b적표체명현상승[(10.6±3.2)%여(43.6±3.4)%].sMICA양성적유선암환자NK세포여세포인자IL-15공배양,NK세포적살류활성、NKG2D적표체명현승고,KIR(CD158b)적표체명현하강.결론 유선암외주혈혈청중sMICA가통과하조NK세포NKG2D표체이급상조KIR표체,강저NK세포살류활성.IL-15가역전sMICA대NK세포적면역하조작용.
Objective To observe the expression of cytotoxicity and receptors on NK cells in breast cancer,and investigate the impact of soluble MICA(sohble MHC class Ⅰ-related molecules A,sMICA) on NK cells receptors expression and cytotoxicity.Methods ELISA was used to examine the sMICA in peripheral blood.The expressions of activated receptor(NKG2D),killer inhibitory receptor (KIR)(CD158b) and NK cells were identified by flow cytometry(FCM).Cytotoxicity of NK cells to breast cancer were tested by MTT.Results sMICA was (205.36±71.27)ng/L in breast cancer patients and 81.6 % samples were detected.There were positive correlations between sMICA levels with breast cancer stages.There were no difference of NK cells percentage between breast cancer and healthy person.The cytotoxicity of NK cells and expressions of NKG2D were obviously lower in breast cancer with sMICA(+) than in healthy person,but CD158b was higher in healthy person.After cultured with sMICA,NK cells cytotoxicity decreased from(76.2±6.7)% to(48.4±4.1)% and the expression of NKG2D reduced from(92.5±7.1)% to (62.5±6.4)%,but the the expression of CD158b increased from(10.6±3.2)% to (43.6±3.4)%.IL-15 up regulated the expression of NKG2D and NK cells cytotoxicity,but decreased the expression of CD158b by co-culturation with IL-15 and sMICA in sMICA+ patients with breast cancer.Conclusion sMICA reduced the expression of NKG2D and increased the expression of Kill,which lead to the down regulation of NK cells cytotoxicity.IL-15 can reverse this effect.